C. Nicholson

C. Nicholson

Directeur/Membre du Conseil chez ACTINIUM PHARMACEUTICALS, INC.

Fortune : 420 $ au 31/05/2026

71 ans
Health Technology
Commercial Services
Finance

Profil

C.
David Nicholson
is Chairman at Exscientia AI Ltd. since 2020.
Non-Executive Chairman at Wild Bioscience Ltd. since 2023.
Director at Rapalogix Health, Inc., Science Exchange, Inc. since 2018, Tarus Therapeutics, Inc. since 2020, Volastra Therapeutics, Inc., and Gilde Healthcare Partners, Inc. since 2020.
Lead Independent Director at Actinium Pharmaceuticals, Inc. since 2017.
Former Non-Executive Chairman at Exscientia Ltd. from 2023 to 2024.
Vice Chairman at Transcelerate Biopharma, Inc. Former Director at Actinium Pharmaceuticals, Inc. Director at Cactus Ventures, Inc. from 2012 to 2013.
Independent Director at Adverum Biotechnologies, Inc. from 2023 to 2025.
Senior Vice President at Forest Laboratories, Inc. Vice President-Licensing & Knowledge Management at Merck & Co., Inc. from 2009 to 2011.
SVP-Global Project Management & Drug Safety at Schering-Plough Corp.
from 2007 to 2009.
Chief Technology Officer & Executive VP at Bayer CropScience AG from 2012 to 2014.
Executive Vice President-Research & Development at Organon International, Inc. from 1988 to 2007 and at Organon Biosciences, Inc. in 2007.
Executive VP, Chief Research & Development Officer at Allergan UC from 2015 to 2020.
CTO, Head-Research & Development at Bayer Crop Science Solutions LLC from 2012 to 2014.
Education includes an undergraduate degree from The University of Manchester in 1975 and a doctorate from The University of Wales in 1980.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
15/10/2025 333 ( 0 % ) 420 $ 31/05/2026

Postes actifs de C. Nicholson

SociétésPosteDébut
ACTINIUM PHARMACEUTICALS, INC. Directeur/Membre du Conseil 01/01/2008
Directeur/Membre du Conseil 28/06/2018
Private Equity Investor 01/09/2020
Directeur/Membre du Conseil -
Président 03/11/2023
Président 01/10/2020
Directeur/Membre du Conseil 14/05/2020

Anciens postes connus de C. Nicholson

SociétésPosteFin
ADVERUM BIOTECHNOLOGIES, INC. Directeur/Membre du Conseil 09/12/2025
EXSCIENTIA PLC Président 12/02/2024
░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░ ░░░░░░░ ░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░ ░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de C. Nicholson

Formation de C. Nicholson

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

61

Relations au 1er degré

22

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées22

Health Technology

Health Technology

Health Technology

Commercial Services

Finance

Consumer Services

Process Industries

Health Technology

Consumer Services

Organon Biosciences, Inc.

Health Technology

Technology Services

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Technology Services

Commercial Services

  1. Bourse
  2. Insiders
  3. C. Nicholson
DERNIÈRES HEURES | -40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT
🔇